A detailed history of Proficio Capital Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Proficio Capital Partners LLC holds 6,400 shares of ABBV stock, worth $1.06 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,400
Previous 5,813 10.1%
Holding current value
$1.06 Million
Previous $900,000 29.44%
% of portfolio
0.13%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $93,814 - $106,892
587 Added 10.1%
6,400 $1.17 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $22,979 - $25,879
-167 Reduced 2.79%
5,813 $900,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $46,088 - $53,354
345 Added 6.12%
5,980 $891,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $115,018 - $143,133
-868 Reduced 13.35%
5,635 $759,000
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $149 Million - $172 Million
-1,029,913 Reduced 99.37%
6,503 $1.04 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $149 Million - $172 Million
1,030,308 Added 16868.17%
1,036,416 $165 Million
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $101,381 - $121,582
733 Added 13.64%
6,108 $987,000
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $13,152 - $15,085
98 Added 1.86%
5,375 $721,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $56,148 - $71,383
408 Added 8.38%
5,277 $808,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $118,122 - $146,556
-895 Reduced 15.53%
4,869 $789,000
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $16,007 - $20,253
149 Added 2.65%
5,764 $781,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $12,342 - $14,010
-116 Reduced 2.02%
5,615 $606,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $23,882 - $26,606
-227 Reduced 3.81%
5,731 $646,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $48,285 - $53,156
472 Added 8.6%
5,958 $645,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $30,747 - $41,511
382 Added 7.48%
5,486 $588,000
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $28,006 - $32,870
326 Added 6.82%
5,104 $420,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $84,228 - $112,710
1,148 Added 31.63%
4,778 $469,000
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $234,135 - $354,977
3,630 New
3,630 $261,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $120,606 - $145,003
-1,915 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $9,395 - $12,009
143 Added 8.07%
1,915 $139,000
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $20,904 - $24,604
271 Added 18.05%
1,772 $143,000
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $6,695 - $8,256
86 Added 6.08%
1,501 $138,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $2,934 - $3,261
-33 Reduced 2.28%
1,415 $134,000
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $8,529 - $10,091
95 Added 7.02%
1,448 $134,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $180,891 - $242,230
-1,966 Reduced 59.23%
1,353 $128,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $3,671 - $4,026
41 Added 1.25%
3,319 $321,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $228,968 - $292,463
3,278
3,278 $291,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.